GLP-1 Drugs: What They Are, How They Work & Who They're For

What Are GLP-1 Drugs?

If you've been researching medical weight loss, you've likely encountered terms like Ozempic, Wegovy, Mounjaro, or Zepbound. These are brand names for a class of medications known as drugs GLP-1 — or more precisely, GLP-1 receptor agonists. Originally developed to treat type 2 diabetes, these medications have emerged as some of the most effective tools in evidence-based weight management.

GLP-1 stands for glucagon-like peptide-1, a hormone your body naturally produces in your intestines after eating. GLP-1 drugs mimic this hormone, triggering the same metabolic signals that regulate appetite, blood sugar, and digestion. The result: reduced hunger, improved satiety, and clinically significant weight loss when combined with lifestyle changes.

Unlike stimulant-based diet pills or quick-fix supplements, drugs GLP-1 are FDA-approved, clinician-prescribed medications backed by rigorous clinical trials involving tens of thousands of participants. They represent a fundamental shift in how medicine approaches weight management — treating it as a chronic metabolic condition rather than a willpower problem.

How GLP-1 Drugs Work in Your Body

When you eat, your gut releases natural GLP-1 to communicate with your brain, pancreas, and stomach. This hormone:

The problem is that natural GLP-1 breaks down within minutes. Drugs GLP-1 are engineered to last much longer — semaglutide remains active for about a week, while tirzepatide (which also activates a second hormone pathway called GIP) has a similar duration. This extended activity means one weekly injection can provide consistent appetite regulation and metabolic benefits.

The mechanism isn't about forcing weight loss. It's about restoring communication between your gut and brain that may have been disrupted by insulin resistance, chronic dieting, or metabolic dysfunction. Patients consistently report feeling less preoccupied with food, experiencing genuine fullness from smaller portions, and having fewer cravings — not through deprivation, but through hormonal signaling that works with your body's existing systems.

The Main GLP-1 Drugs Available Today

Semaglutide

Semaglutide is available under two primary brand names:

The STEP clinical trial program demonstrated that adults taking semaglutide 2.4 mg lost an average of 15-17% of their body weight over 68 weeks when combined with lifestyle modification. Participants also showed improvements in cardiovascular risk factors, blood pressure, and metabolic markers.

Body Good Studio offers compounded semaglutide for eligible patients, providing an accessible pathway to clinician-supervised treatment with transparent pricing and discreet home delivery.

Tirzepatide

Tirzepatide is a dual agonist, activating both GLP-1 and GIP (glucose-dependent insulinotropic polypeptide) receptors. It's available as:

The SURMOUNT trials showed even more robust results, with participants losing an average of 20-22% of their body weight at the highest dose (15 mg weekly). The dual mechanism appears to offer additional metabolic benefits, though individual responses vary.

For those curious about tirzepatide but hesitant to commit, Body Good Studio's tirzepatide one-time trial allows you to try a single month with full clinician support before deciding on a longer-term program.

Oral GLP-1 Options

While most GLP-1 drugs are administered via subcutaneous injection, oral semaglutide (brand name Rybelsus) is FDA-approved for type 2 diabetes. Oral formulations require daily dosing and have somewhat lower bioavailability than injectable versions, but they offer an alternative for adults who prefer to avoid needles. Body Good Studio offers an oral GLP-1 (no commitment) starter option for those exploring medical weight loss without injections.

Who Qualifies for GLP-1 Drugs?

The FDA has approved drugs GLP-1 for chronic weight management in adults with:

Clinicians may also consider additional factors including:

Access typically begins with a comprehensive medical evaluation. Body Good Studio's new patient consultation includes a full medical history review, eligibility assessment, and personalized treatment plan — most members receive their plan within 24 hours.

Insurance Coverage and Cost Considerations

Insurance coverage for drugs GLP-1 varies significantly by plan, diagnosis, and state. Some important realities:

If you have insurance and want to understand your coverage options, Body Good Studio's GLP-1 insurance eligibility review provides clinician-supported guidance through the prior authorization pathway, BMI eligibility verification, and plan-specific coverage details.

For those paying out of pocket, telehealth platforms with transparent pricing often provide significant savings compared to traditional retail pharmacy costs. You can review all available programs to compare options.

What to Expect: Side Effects and Management

The most common side effects of drugs GLP-1 are gastrointestinal and typically emerge when starting treatment or increasing doses:

Most side effects diminish within 4-8 weeks as your body adapts. Strategies that help include:

For persistent nausea that interferes with daily life, prescription anti-nausea medications like ondansetron can help you stay on protocol without unnecessary discontinuation. Managing side effects proactively is key to long-term adherence.

Rare but serious risks include pancreatitis, gallbladder disease, and hypoglycemia (especially if combined with insulin or sulfonylureas). Any severe abdominal pain, persistent vomiting, or vision changes warrant immediate medical attention.

What Happens If GLP-1 Drugs Aren't Right for You?

Not everyone qualifies for GLP-1 medications, and some people don't tolerate them well despite best efforts. Alternatives exist.

The combination of bupropion and naltrexone is an FDA-approved non-GLP-1 option for weight management. It works through different mechanisms — bupropion affects dopamine and norepinephrine pathways related to reward and appetite, while naltrexone modulates opioid receptors involved in cravings. This combination can be effective for adults who cannot use GLP-1 drugs due to contraindications or intolerable side effects.

Other clinician-supervised options may include phentermine (short-term), metformin (off-label, primarily for insulin resistance), or structured nutrition and behavior modification programs. The right approach depends on your individual health profile, goals, and preferences.

Telehealth Access: How It Works

Traditional barriers to GLP-1 drugs — long wait times for endocrinology referrals, insurance denials, opaque pricing, or stigma in face-to-face appointments — have led many adults to telehealth platforms.

Here's how clinician-prescribed telehealth typically works:

1. Eligibility screening — You complete a brief health questionnaire (take our free 60-second quiz to see if you qualify)
2. Clinician review — A licensed physician or nurse practitioner reviews your medical history, current medications, and weight loss goals
3. Treatment plan — If appropriate, your clinician prescribes a GLP-1 medication, determines starting dose, and outlines monitoring protocol
4. Medication delivery — Your prescription is sent to a licensed pharmacy and shipped discreetly to your home
5. Ongoing support — You have access to your care team for dose adjustments, side effect management, and questions

Body Good Studio operates in this model: physician-led, insurance-friendly when applicable, with transparent pricing and bilingual (English and Spanish) support. Most members receive their treatment plan within 24 hours of completing intake.

Combining GLP-1 Drugs with Lifestyle Changes

Drugs GLP-1 are not a replacement for nutrition and movement — they're a tool that makes sustainable behavior change more achievable. Clinical trials included lifestyle counseling as a standard component, and real-world effectiveness depends on it.

Practical guidance that works alongside GLP-1 treatment:

Body Good Studio includes nutrition coaching as part of comprehensive programs, recognizing that medication + education delivers better long-term outcomes than medication alone. For more evidence-based strategies, explore additional articles on our blog.

Frequently Asked Questions

How long do I need to take GLP-1 drugs?

GLP-1 medications are approved for chronic use, meaning they're intended as long-term treatment rather than a short-term fix. Clinical trial data extends beyond two years, and many patients continue treatment indefinitely to maintain weight loss. Discontinuation often leads to weight regain, similar to stopping treatment for hypertension or diabetes. Your clinician will help you determine the right duration based on your goals and response.

Can I drink alcohol while taking GLP-1 drugs?

Moderate alcohol consumption isn't contraindicated, but many patients report reduced tolerance or interest in alcohol while on GLP-1 therapy. Since these medications slow gastric emptying, alcohol may affect you differently. Additionally, alcohol provides empty calories that can interfere with weight loss goals. Discuss your habits openly with your clinician.

Will I regain weight if I stop taking GLP-1 drugs?

Weight regain after discontinuation is common, though not universal. Studies show that most people regain a significant portion of lost weight within a year of stopping. However, those who've built sustainable nutrition and activity habits during treatment tend to maintain more of their loss. Think of GLP-1 drugs as a tool for achieving and maintaining a healthier weight, not a temporary intervention.

Are compounded GLP-1 drugs safe?

Compounded medications are prepared by licensed pharmacies under FDA oversight, but they're not identical to FDA-approved branded drugs. Compounding became widely available for semaglutide and tirzepatide during shortages of brand-name versions. Quality varies by pharmacy, so it's essential to work with a reputable telehealth provider that uses licensed, accredited compounding pharmacies and provides proper clinician oversight.

Can I use GLP-1 drugs if I don't have diabetes?

Yes. Wegovy (semaglutide) and Zepbound (tirzepatide) are FDA-approved specifically for chronic weight management in adults without diabetes who meet BMI criteria. The medications work similarly whether or not you have type 2 diabetes, though dosing and monitoring protocols may differ slightly.

Ready to Start Your Weight Loss Journey?

Body Good Studio's clinician-prescribed programs make medical weight loss accessible, affordable, and personalized. Whether you're exploring drugs GLP-1 for the first time or looking for better support than you've received elsewhere, our physician-led platform offers transparent pricing, insurance-friendly options, and care in English or Spanish. Take our free 60-second quiz to see if you qualify — most members get a treatment plan in under 24 hours.